D-0564-2022 Class II Terminated

Recalled by ANI Pharmaceuticals, Inc. — Baudette, MN

FDA drug recall D-0564-2022 was initiated by ANI Pharmaceuticals, Inc. on Feb 15, 2022 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 25, 2022). Affected quantity: 73,920 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 23, 2022
Initiation Date
Feb 15, 2022
Termination Date
Oct 25, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
73,920 bottles

Product description

Alprazolam Tablets, USP 0.25 mg, packaged in a) 100-count bottles (NDC 67253-900-10), b) 500-count bottles (NDC 67253-900-50), and c) 1000-count bottles (NDC 67253-900-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

Reason for recall

cGMP Deviations

Distribution pattern

Nationwide within the United States

Code information

Lot #: a) 19C003A, Exp. Date 03/2022; 19G002A, exp. date 07/2022; b) 19C004B, Exp. Date 03/2022; c) 19C048C, Exp. Date 03/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0564-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0564-2022. Report a data issue: hello@regdatalab.com.